35 related articles for article (PubMed ID: 12474053)
1. Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.
Wang Q; Zhang J; Guo Z
Bioorg Med Chem; 2007 Dec; 15(24):7561-7. PubMed ID: 17892942
[TBL] [Abstract][Full Text] [Related]
2. Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cells.
Murate M; Yokoyama N; Tomishige N; Richert L; Humbert N; Pollet B; Makino A; Kono N; Mauri L; Aoki J; Sako Y; Sonnino S; Komura N; Ando H; Kaneko MK; Kato Y; Inamori KI; Inokuchi JI; Mély Y; Iwabuchi K; Kobayashi T
Cell Mol Life Sci; 2023 May; 80(6):167. PubMed ID: 37249637
[TBL] [Abstract][Full Text] [Related]
3. Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma.
Irie RF; Ollila DW; O'Day S; Morton DL
Cancer Immunol Immunother; 2004 Feb; 53(2):110-7. PubMed ID: 14564483
[TBL] [Abstract][Full Text] [Related]
4. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells.
Gu Y; Zhang J; Mi W; Yang J; Han F; Lu X; Yu W
Breast Cancer Res; 2008; 10(1):R1. PubMed ID: 18171481
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies.
Zhang J; Terreni M; Liu F; Sollogoub M; Zhang Y
Biomed Pharmacother; 2024 May; 176():116824. PubMed ID: 38820973
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.
Mazorra Z; Mesa C; Fernández A; Fernández LE
Cancer Immunol Immunother; 2008 Dec; 57(12):1771-80. PubMed ID: 18351335
[TBL] [Abstract][Full Text] [Related]
7. A conjugate of an oligosaccharide fragment of tumor-associated ganglioside antigen with hemocyanin is a prototype antitumor vaccine.
Stepanenko RN; Tsvetkov YE; Khatuntseva EA; L'vov VL; Vlasenko RY; Nifant'ev NE; Petrov RV
Dokl Biol Sci; 2007; 415():298-301. PubMed ID: 17929671
[No Abstract] [Full Text] [Related]
8. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
9. Murine models of liver metastasis.
Rusciano D; Lorenzoni P; Burger M
Invasion Metastasis; 1994-1995; 14(1-6):349-61. PubMed ID: 7657528
[TBL] [Abstract][Full Text] [Related]
10. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
Gabri MR; Ripoll GV; Alonso DF; Gómez DE
J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
[TBL] [Abstract][Full Text] [Related]
11. Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.
Gabri MR; Mazorra Z; Ripoll GV; Mesa C; Fernandez LE; Gomez DE; Alonso DF
Clin Cancer Res; 2006 Dec; 12(23):7092-8. PubMed ID: 17145833
[TBL] [Abstract][Full Text] [Related]
12. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.
Alonso DF; Gabri MR; Guthmann MD; Fainboim L; Gomez DE
Int J Oncol; 1999 Jul; 15(1):59-66. PubMed ID: 10375594
[TBL] [Abstract][Full Text] [Related]
13. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
[TBL] [Abstract][Full Text] [Related]
14. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
Dohi T; Nores G; Hakomori S
Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
